Clinical Trial Update: Aspirin Responsiveness in Women at Risk for Cardiac Events [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing aspirin responsiveness in women at risk for cardiac events has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Creighton University | Conditions: Heart Disease | Phase 4 | Status: COMPLETED | Results posted: 2012-12-04